ATOMOXAPEX 18MG 30 CAPS

DESCRIPTION: ATOMOXETINE IS THE FIRST NON-STIMULANT DRUG APPROVED FOR THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD). DOSE: DOSING OF CHILDREN AND ADOLESCENTS UP TO 70 KG BODY WEIGHT INITIAL: THE RECOMMENDED DOSE IS 0.5 MG/KG AND INCREASED AFTER A MINIMUM OF 3 DAYS TO A TARGET TOTAL DAILY DOSE OF APPROXIMATELY 1.2 MG/KG ADMINISTERED EITHER AS A SINGLE DAILY DOSE IN THE MORNING OR AS EVENLY DIVIDED DOSES IN THE MORNING AND LATE AFTERNOON/EARLY EVENING. THE TOTAL DAILY DOSE IN CHILDREN AND ADOLESCENTS SHOULD NOT EXCEED 1.4 MG/KG OR 100 MG. DOSING OF CHILDREN AND ADOLESCENTS OVER 70 KG BODY WEIGHT AND ADULTS INITIAL: THE RECOMMENDED DOSE IS 40 MG AND INCREASED AFTER A MINIMUM OF 3 DAYS TO A TARGET TOTAL DAILY DOSE OF APPROXIMATELY 80 MG ADMINISTERED EITHER AS A SINGLE DAILY DOSE IN THE MORNING OR AS EVENLY DIVIDED DOSES IN THE MORNING AND LATE AFTERNOON/EARLY EVENING. MAXIMUM: 100MG.